While semaglutidea GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight managementis primarily associated with gastrointestinal side effects, some patients report skin-related symptoms during treatment
Consistency maximizes absorption
Aim for at least 30 minutes of physical activity most days of the week to maximize weight loss and overall health
In conclusion, a recommendation for NAC use for NUD cannot be made at this time, as further research is required
They also have differences in their approved uses, costs, and side effects
Clinical outcomes depend on dose, consistency of use, and individual genetic response rather than whether the medication comes from a large pharmaceutical company or a licensed 503A compounding pharmacy